Pharyngostomy tubes for gastric conduit decompression.
OBJECTIVE
This article illustrates our operative technique for pharyngostomy tube placement and describes our clinical experience with pharyngostomy use for gastric conduit decompression after esophagectomy.


METHODS
We retrospectively reviewed patients undergoing pharyngostomy tube placement for gastric conduit decompression after esophagectomy from January 2008 to August 2009. Patients were included if they had a pharyngostomy tube placed at esophagectomy (prophylactic placement) or as a means of decompression after postesophagectomy anastomotic leak (therapeutic placement). We collected operative and clinical data and performed a descriptive statistical analysis.


RESULTS
We placed 25 pharyngostomy tubes for gastric conduit decompression after esophagectomy. Eleven were placed prophylactically (44%); the remaining 14 were placed therapeutically (56%) after anastomotic leak. Prophylactic pharyngostomy tubes remained in place a median of 8 days (range 4-17 days), whereas therapeutic pharyngostomy tubes were left in place a median of 15 days (range 7-125 days). There were 4 infectious complications (16%) unrelated to length of pharyngostomy use: 2 cases of cellulitis (resolved with antibiotics, tube remaining in place) and 2 superficial abscesses after tube removal requiring bedside débridement. Seventy-two percent of patients underwent swallow evaluation; 22% of these patients had radiographic evidence of aspiration.


CONCLUSIONS
Pharyngostomy tube placement for gastric conduit decompression after esophagectomy is simple, and tubes can stay in place for prolonged periods. Our experience suggests that pharyngostomy tubes are a safe alternative to nasogastric drainage.
Rueth
Natasha M
NM
Department of Surgery, Division of General Thoracic and Foregut Surgery, University of Minnesota, Minneapolis, Minn, USA.
Lee
Natasha
N
Groth
Shawn S
SS
Stranberg
Sarah C
SC
Maddaus
Michael A
MA
D'Cunha
Jonathan
J
Andrade
Rafael S
RS
D019299:Decompression, Surgical / Q000009:adverse effects / Q000295:instrumentation*; D016629:Esophagectomy / Q000009:adverse effects; D006801:Humans; D007441:Intubation, Gastrointestinal / Q000009:adverse effects / Q000295:instrumentation*; D008910:Minnesota; D010613:Pharyngostomy / Q000009:adverse effects / Q000295:instrumentation*; D011183:Postoperative Complications / Q000517:prevention & control / Q000601:surgery*; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome